Table 1: Characteristics of 33 patients with BCLM

Age at primary (year)

46.2 (27 ~ 70)

Stage

0 2, 6, 8, 6, 9, unknown 2

Timing of liver metastases

synchronous (n)

6

     metachronous (n)

27

     interval from primary treatment (month)

45.7 (9 ~ 227)

Adjuvant therapy

   after primary operation

C* + E† 11, C 8, E 4

prehepatic-operation

C 5, C + E 3, E 2, C + T‡ 1,

after liver operation

C 12, C + T 8, C + E 6, E 2, C + T + E 1, T 1

Number of liver metastases (n)

6.4 (1 ~ 31)

Maximal tumor diameter(mm)

38.9 (12.3 ~ 120.0)

Type of liver operation

MCN§ 14, HR¶ 11, HR + MCN 8

Extrahepatic metastatic disease

before liver metastases

bone 3, lung 1, LN# 1

at liver metastases

LN 4, bone 5, lung 2

peritoneal dissemination 1, chest wall 1

after liver metastases

bone 13, brain 5, LN 4, lung 4, ovary 3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*chemotherapy; †endocrine therapy; ‡Trastuzumab; §microwave coagule-necrotic therapy; ¶hepatic resection; #lymph node